Agilon Health Inc (AGL)
NYSE:AGL
AGL Stock Chart & Stats
$0.43
$0.02(1.16%)
At close: 4:00 PM EST
$0.43
$0.02(1.16%)
Day’s Range― - ―
52-Week Range$0.34 - $6.08
Previous CloseN/A
Volume1.09M
Average Volume (3M)6.12M
Market Cap
$177.23M
Enterprise Value$40.33M
Total Cash (Recent Filing)$285.14M
Total Debt (Recent Filing)$36.81M
Price to Earnings (P/E)―
Beta1.08
Next Earnings
May 12, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.46
Shares Outstanding414,869,750
10 Day Avg. Volume3,683,753
30 Day Avg. Volume6,117,393
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)2.25
Price to Sales (P/S)0.05
P/FCF Ratio-2.40
Enterprise Value/Market Cap0.23
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit-0.23
Enterprise Value/Ebitda-0.11
Forecast
1Y Price Target
$0.71Price Target Upside65.12% Upside
Rating ConsensusHold
Number of Analyst Covering10
EPS Forecast (FY)-0.24
Revenue Forecast (FY)$5.52B
Bulls Say, Bears Say
Bulls Say
Liquidity And FinancingAnalyst points to an extended credit facility and a projected cash balance that should provide runway while profitability recovers amid medical cost and regulatory uncertainty.
Operational OptimizationManagement suspended growth to pursue portfolio optimization and improved data visibility for most members, measures that could enable tighter care management and higher margins.
Profitability GuidanceAnalyst highlights guidance toward breakeven adjusted EBITDA driven by improved Medicare Advantage rates, strengthened payer contracts and reduced exposure to Part D, which could support margin recovery.
Bears Say
Forecasting And Cash ConcernsAnalyst expresses concern that ongoing difficulty forecasting costs, missed profitability targets and a constrained cash position increase uncertainty around the company's ability to deliver on guidance.
Medical Cost And Margin RiskAnalyst warns that unfavorable prior‑year adjustments and worsening medical cost trends could prevent the company from achieving the planned medical loss ratios and margin improvement.
Membership And Contract ExitsAnalyst notes expected membership declines as management exits certain Medicare Advantage contracts, which could reduce revenue scale and hinder growth prospects.
Agilon Health News
AGL FAQ
What was Agilon Health Inc’s price range in the past 12 months?
Agilon Health Inc lowest stock price was $0.34 and its highest was $6.08 in the past 12 months.
What is Agilon Health Inc’s market cap?
Agilon Health Inc’s market cap is $177.23M.
When is Agilon Health Inc’s upcoming earnings report date?
Agilon Health Inc’s upcoming earnings report date is May 12, 2026 which is in 46 days.
How were Agilon Health Inc’s earnings last quarter?
Agilon Health Inc released its earnings results on Feb 25, 2026. The company reported -$0.46 earnings per share for the quarter, missing the consensus estimate of -$0.283 by -$0.177.
Is Agilon Health Inc overvalued?
According to Wall Street analysts Agilon Health Inc’s price is currently Undervalued.
Does Agilon Health Inc pay dividends?
Agilon Health Inc pays a Quarterly dividend of $0.45 which represents an annual dividend yield of N/A. See more information on Agilon Health Inc dividends here
What is Agilon Health Inc’s EPS estimate?
Agilon Health Inc’s EPS estimate is 0.06.
How many shares outstanding does Agilon Health Inc have?
Agilon Health Inc has 414,869,750 shares outstanding.
What happened to Agilon Health Inc’s price movement after its last earnings report?
Agilon Health Inc reported an EPS of -$0.46 in its last earnings report, missing expectations of -$0.283. Following the earnings report the stock price went up 18.8%.
Which hedge fund is a major shareholder of Agilon Health Inc?
Currently, no hedge funds are holding shares in AGL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Agilon Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$0.71 (65.12% Upside)
$0.71 (65.12% Upside)
Blogger Sentiment
Neutral
AGL Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 176.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $50.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-90.46%
12-Months-Change
Fundamentals
Return on Equity
-116.65%
Trailing 12-Months
Asset Growth
-26.68%
Trailing 12-Months
Company Description
Agilon Health Inc
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
AGL Company Deck
AGL Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call communicated a clear, quantified plan for a material financial turnaround in 2026 — including specific revenue, medical margin and adjusted EBITDA targets — supported by strengthened data/analytics, scaled clinical pathways (CHF adoption >90%), quality improvement (composite ~4.2 stars) and $35M of operating cost reductions. However, significant 2025 losses (FY adjusted EBITDA -$296M), elevated and volatile medical cost trends (2025 ~6.5%, 2026 assumed gross 7.5%/net 7.0%), membership contraction from contract exits (≈50k MA members), and regulatory uncertainty around CMS’ rate notice present meaningful near-term risks. On balance, the call presented balanced progress and material challenges: management provided credible levers and quantified guidance for improvement, but execution and external factors (cost trends, CMS rates, claims visibility) are non‑trivial risks to achieving the stated goals.View all AGL earnings summariesAGL Stock 12 Month Forecast
Average Price Target
$0.71
▲(65.12% Upside)
Technical Analysis
AMN Healthcare Services
―
Cross Country Healthcare
―
InnovAge Holding
―
P3 Health Partners
―
biote
―
Ownership Overview
2.57% Insiders
13.16% Mutual Funds
40.69% Other Institutional Investors
34.96% Public Companies and
Individual Investors